18.65 0.00 (0.00%)
After hours: 7:22PM EDT
Previous Close | 18.10 |
Open | 18.15 |
Bid | 18.65 x 700 |
Ask | 18.75 x 200 |
Day's Range | 17.70 - 18.75 |
52 Week Range | 5.15 - 24.45 |
Volume | 846,028 |
Avg. Volume | 1,519,958 |
Market Cap | 1.161B |
Beta | 0.22 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.81 |
Earnings Date | May 7, 2018 - May 11, 2018 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 28.83 |
LONDON, UK / ACCESSWIRE / April 25, 2018 / Active-Investors.com has just released a free research report on Dynavax Technologies Corp. (NASDAQ: DVAX) ("Dynavax"). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=DVAX as the Company's latest news hit the wire. On April 23, 2018, the Company announced that the Centers for Disease Control and Prevention (CDC) has published the Advisory Committee of Immunization Practices' (ACIP) Recommendations for the use of HEPLISAV-B® [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for adults in the US, in the Morbidity and Mortality Weekly Report (MMWR) dated April 19, 2018.
BERKELEY, Calif., April 23, 2018-- Dynavax Technologies Corporation today announced that the Centers for Disease Control and Prevention published the Advisory Committee of Immunization Practices’ Recommendations ...
Demonstrates potential to achieve long-term, systemic responses Combination therapy was well tolerated Additional SD-101 data in head and neck squamous cell carcinoma presented at AACR. BERKELEY, Calif., ...
Gainers: NF Energy Saving Corp (NASDAQ: NFEC ) shares are up 8 percent after a 13-D filing from Bi Yongquan showed a 19.8-percent stake. Dynavax Technologies Corporation (NASDAQ: DVAX ) shares are up ...
BERKELEY, Calif., April 16, 2018-- Dynavax Technologies Corporation today announced data from its ongoing Phase 1 b/2 study investigating SD-101, Dynavax's intratumoral TLR9 agonist, in combination with ...
Dynavax Technologies Corp. shares rose 14% in premarket trade Monday after the company released promising data in conjunction with the annual American Association for Cancer Research meeting, happening ...
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Netflix, Inc. (NASDAQ: NFLX ) stock was trading higher ...
Biotech stocks staged a recovery this week, thanks to a deal in the space and news concerning positive pipeline developments. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB ) gained 4.26 percent ...
BERKELEY, Calif., April 03, 2018-- Dynavax Technologies Corporation today announced that on March 29, 2018 the Compensation Committee of Dynavax’ s Board of Directors approved the grant of inducement stock ...
The latest earnings update Dynavax Technologies Corporation’s (NASDAQ:DVAX) released in December 2017 revealed company earnings became less negative compared to the previous year’s level – great news for investors InvestorsRead More...
Data from Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Durability Data in Advanced Metastatic Melanoma. BERKELEY, Calif., March 15, 2018-- Dynavax Technologies Corporation announced today ...
On a per-share basis, the Berkeley, California-based company said it had a loss of 45 cents. Losses, adjusted for amortization costs, came to 43 cents per share. The biopharmaceutical company posted revenue ...
HEPLISAV-B Launched in the United States. Phase 2 Data in Two Immuno-oncology Programs Planned for First Half 2018. BERKELEY, Calif., March 08, 2018-- Dynavax Technologies Corporation today reported financial ...
BERKELEY, Calif., March 05, 2018-- Dynavax Technologies Corporation announced today that Eddie Gray, Dynavax’ s Chief Executive Officer, will present at the Cowen & Co. 38 th Annual Health Care Conference ...
Just because a stock doubles doesn't mean it's time to sell. Very often, it's still worth buying. Find out what the answer is for these three.
BERKELEY, Calif., March 02, 2018-- Dynavax Technologies Corporation announced today that Stanley A. Plotkin, M.D. has indicated his intention to step down from the Board of Directors effective from the ...
BERKELEY, Calif., March 01, 2018-- Dynavax Technologies Corporation today announced that on March 1, 2018 the Compensation Committee of Dynavax’ s Board of Directors approved the grant of inducement stock ...
NEW YORK (AP) — A federal advisory panel on Wednesday recommended a new vaccine against hepatitis B.
What Happened Dynavax Technologies Corporation (NASDAQ: DVAX ) traded up 3.7 percent Wednesday after management announced the Centers for Disease Control and Prevention will recommend HEPLISAV-B as an ...
Dynavax Technologies Corp. shares rose 2.3% in moderate Wednesday morning trade after the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices unanimously voted in ...
BERKELEY, Calif., Feb. 21, 2018-- Dynavax Technologies Corporation today announced that the Centers for Disease Control and Prevention’ s Advisory Committee on Immunization Practices voted unanimously ...
Proceeds to be Used to Commercialize HEPLISAV-B™ in United States and Advance Company’ s Immuno-Oncology Product Candidates. Company Deploying HEPLISAV-B Field Sales Team. BERKELEY, Calif., Feb. 20, 2018-- ...
Volatility is the name of the game in profitable trading, and it's all the more relavant in the biotech space, which is subject to many make-or-break catalytic events . This apart, usual market-moving ...
BERKELEY, Calif., Feb. 14, 2018-- Dynavax Technologies Corporation announced today that Eddie Gray, Dynavax’ s chief executive officer, will participate in a fireside chat at the 2018 RBC Capital Markets ...
Here are a few key events I will be watching closely for in the months ahead on stocks I think are buys at current levels.